Tua Tagovailoa in a great spot? No real help for C.J. Stroud? A wildly player-friendly deal for Tyler Linderbaum? Here's the best and worst of free agency.

Good morning. Welcome to this fireside chat with Insmed. I'm Joe Schwartz from the biopharma equity research team at Leerink Partners, and it's my great pleasure to be joined by Sara Bonstein, CFO.